HAVCR2 and tuberculosis: Given the high risk of mycobacterium tuberculosis infection in HIV-infected patients, especially in endemic areas, the results suggest the beneficial effects of inhibiting galectin-9/Tim-3 interaction in controlling mycobacterium tuberculosis growth in HIV-infected patients with co-infection by mycobacterium tuberculosis.